Silexion Therapeutics enters inducement agreement for exercise of ~2M warrants at $0.50, raising ~$1M

Silexion Therapeutics Corp

Holders of 1,995,092 existing warrants (Series A/B at $4.00, Prior Inducement at $11.32) agree to exercise at reduced price of $0.50 per share.
Gross proceeds of approximately $1.0 million expected from the warrant exercise, with H.C. Wainwright as placement agent earning 7% cash fee.
Company will issue new Series C (2,045,000) and Series D (1,945,184) warrants exercisable at $0.50, totaling 3,990,184 new warrant shares.
Closing expected on or about May 18, 2026, with net proceeds used for general corporate purposes.
Placement agent also receives warrants to purchase up to 139,656 ordinary shares at $0.625 per share.

item 1.01item 3.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.